| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 |
| filingDate |
1992-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1993-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce3b912496c96fde69883c3e1664219d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_809c05f43c2e67a5c804f09d87541a48 |
| publicationDate |
1993-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5250572-A |
| titleOfInvention |
(R)-norfluoxetine in method for occupying serotonin IC receptors |
| abstract |
The present invention provides (R)-norfluoxetine and pharmaceutically acceptable salts thereof capable of selectively occupying 5HT1c receptors. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009264470-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2162560-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009036426-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003087938-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004018959-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0100202-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9638152-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I395945-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008140450-A1 |
| priorityDate |
1990-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |